Please assess the completion status of the following clinical trial:

Trial Title: Light Treatment Effectiveness (LITE) Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Willing and able to provide informed consent (age 18+) or parental permission and assent (ages 12-17)~2. Age 12 or older~3. Plaque or guttate psoriasis predominantly located on trunk and/or extremities, with a physician global assessment average of \>1.0, and considered a candidate for phototherapy~4. Patient is deemed willing and able to comply with either in-office or in-home phototherapy:~   1. In office: Able to travel about 3 times per week for 12 weeks from home, work and/or school during business hours of local site~  2. In home: Has space to accommodate home phototherapy unit and patient (or if 12-17, parent), willing and able to follow home phototherapy instructions~5. New or established patient in the practice~Exclusion Criteria:~1. Patients who are judged unable or unwilling to comply with either in office or in home phototherapy due to time, work, school, or other financial constraints~2. Patients judged unable to follow home phototherapy protocol due to failure to demonstrate understanding of the following:~   1. How to operate the phototherapy device~  2. How to follow the dosing protocol~  3. Requirement to wear protective eyewear and genital protection equipment~3. Patients with known history of lack of efficacy to phototherapy or treated with phototherapy 14 days prior to baseline visit~4. Psoriasis predominantly located on scalp, body folds, genitals, palms and/or soles or with a physician global assessment average of ≤ 1.0~5. Patients deemed unsafe to be treated with phototherapy:~   1. History of photosensitivity or autoimmune disease such as lupus or dermatomyositis which can be aggravated by ultraviolet radiation~  2. History of arsenic intake~  3. Unable to tolerate standing for required duration of treatment due to age or physical function~  4. History of melanoma or multiple non-melanoma skin cancers that in the opinion of the principal investigator contraindicates treatment with phototherapy~6. Clinical site deems the participant is ineligible for reason other than eligibility or screening criteria.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Office Based Phototherapy (Type: OTHER): Patients randomized to this arm will receive narrow band phototherapy in a clinical setting via narrow band phototherapy clinic units.
- Home Based Phototherapy (Type: ACTIVE_COMPARATOR): Patients randomized to this arm will receive narrow band phototherapy in a home setting via Daavlin 7 series 3 panel narrow band phototherapy home units.

Based on this trial design, predict the completion outcome and termination type (if applicable).